Abstract
α2-Adrenoceptors modulating the release of dopamine were identified and characterized in slices of the head of the rabbit caudate nucleus. Release of endogenous dopamine was measured by fast cyclic voltammetry as the increase in the extracellular concentration of dopamine elicited by electrical stimulation. The electrochemical signal was identified as dopamine by means of the oxidation potential, the voltammogram and the fact that the signal was not changed by desipramine, which inhibits the high affinity uptake of noradrenaline, but was greatly increased by nomifensine, which in addition inhibits the high affinity uptake of dopamine.
Stimulation by 6 pulses/100 Hz increased the extracellular concentration of dopamine by about 85 nM. The selective α2-adrenoceptor agonist 5-bromo-6-(2-imidazolin-2-ylamino)-quinoxaline (UK 14,304) reduced this release with an EC50 of 173 nM and by maximally 75%. The α2-adrenoceptor agonists clonidine and oxymetazoline only tended to cause a decrease. Six drugs, including oxymetazoline, were tested as antagonists against UK 14,304. Their order of antagonist potency (pKD values in brackets) was rauwolscine (8.0) > oxymetazoline (7.5) > 2-(2,6-dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane (WB 4101; 7.3) > phentolamine (7.1) > corynanthine (5.1) ≈ prazosin (< 6). Given alone, the antagonists did not change the release of dopamine elicited by 6 pulses/100 Hz, and the same was true for the dopamine receptor antagonist sulpiride. When caudate slices were stimulated by 10 pulses/1 Hz, sulpiride increased the release of dopamine. Desipramine and rauwolscine, in contrast, again caused no change.
It is concluded that dopaminergic axons in the rabbit caudate nucleus possess release-inhibiting α2-adrenoceptors. The antagonist affinities indicate that they belong to the α2A subtype. In this, they agree with all presynaptic α2-autoreceptors studied so far in rabbits as well as with the α2-heteroreceptors modulating the release of serotonin in rabbit brain cortex, suggesting that at least the majority of presynaptic α2-adrenoceptors in the rabbit are α2A. The agonist sensitivity of the caudate presynaptic α2-adrenoceptors is low in comparison with cerebrocortical presynaptic α2-autoreceptors, possibly due to absence of a receptor reserve.
Similar content being viewed by others
References
Adler CH, Meller E, Goldstein M (1987) Receptor reserve at the alpha-2 adrenergic receptor in the rat cerebral cortex. J Pharmacol Exp Ther 240:508–515
Aghajanian GK, Bunney BS (1977) Dopamine “autoreceptors”: pharmacological characterization by microiontophoretic single cell recording studies. Naunyn-Schmiedeberg's Arch Pharmacol 297:1–7
Agneter E, Drobny H, Singer EA (1991) Estimation of agonist dissociation constants at central presynaptic alpha-2 autoreceptors in the absence of autoinhibition. J Pharmacol Exp Ther 257:19–25
Andén NE, Grabowska M (1976) Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur J Pharmacol 39:275–282
Andén NE, Corrodi H, Fuxe K, Hökfelt B, Hökfelt T, Rydin C, Svensson T (1970) Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci 9:513–523
Briley M (1993) Noradrenergic mechanisms in Parkinson's disease. Trends Pharmacol Sci 14:33–34
Bull DR, Sheehan MJ (1991) Presynaptic regulation of electrically evoked dopamine overflow in nucleus accumbens: a pharmacological study using fast cyclic voltammetry in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 343:260–265
Bull DR, Palij P, Sheehan MJ, Millar J, Stamford JA, Kruk ZL, Humphrey PPA (1990) Application of fast cyclic voltammetry to measurement of electrically evoked dopamine overflow from brain slices in vitro. J Neurosci Methods 32:37–44
Bylund DB (1992) Subtypes of αl- and α2-adrenergic receptors. FASEB J 6:832–839
de Langen CDJ, Hogenboom F, Mulder AH (1979) Presynaptic noradrenergic α-receptors and modulation of 3H-noradrenaline release from rat brain synaptosomes. Eur J Pharmacol 60:79–89
Dubocovich ML (1984) Alpha-2 adrenoceptors modulate [3H]dopamine release from rabbit retina. J Pharmacol Exp Ther 230: 149–155
Ehringer H, Hornykiewicz O (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr 24:1236–1239
Fuder H, Selbach M (1993) Characterization of sensory neurotransmission and its inhibition via α2B-adrenoceptors and via non-α2-receptors in rabbit iris. Naunyn-Schmiedeberg's Arch Pharmacol 347: 394–401
Fuder H, Braun HJ, Schimkus R (1986) Presynaptic alpha-2 adrenoceptor activation and coupling of the receptor-presynaptic effector system in the perfused rat heart: affinity and efficacy of phenethylamines and imidazoline derivatives. J Pharmacol Exp Ther 237: 237–245
Furchgott RE (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds). Catecholamines. Handbook of experimental pharmacology, vol 33, Springer, Berlin, Heidelberg, New York, pp 283–335
Grenhoff J, Svensson TH (1988) Clonidine regularizes substantia nigra dopamine cell firing. Life Sci 42:2003–2009
Grenhoff J, Svensson TH (1989) Clonidine modulates dopamine cell firing in rat ventral tegmental area. Eur J Pharmacol 165:11–18
Lanier SM, Downing S, Duzic E, Homey CJ (1991) Isolation of rat genomic clones encoding subtypes of the α2-adrenergic receptor. J Biol Chem 266:10470–10478
Lategan AJ, Marien MR, Colpaert FC (1992) Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study. Life Sci 50:995–999
Limberger N, Trendelenburg AU (1994) Presynaptic α2-autoreceptors in rabbit kidney: distinct from those in human and rat kidney. Naunyn-Schmiedeberg's Arch Pharmacol 349 [Suppl]:R79
Limberger N, Trout SJ, Kruk ZL, Starke K (1991) “Real time” measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens: role of autoinhibition. Naunyn-Schmiedeberg's Arch Pharmacol 344: 623–629
Limberger N, Trendelenburg AU, Starke K (1992) Pharmacological characterization of presynaptic α2-autoreceptors in rat submaxillary gland and heart atrium. Br J Pharmacol 107:246–255
Link R, Daunt D, Barsh G, Chruscinski A, Kobilka B (1992) Cloning of two mouse genes encoding α2-adrenergic receptor subtypes and identification of a single amino acid in the mouse α2-C10 homolog responsible for an interspecies variation in antagonist binding. Mol Pharmacol 42:16–27
Lupica CR, Cass WA, Zahniser NR, Dunwiddic TV (1990) Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J Pharmacol Exp Ther 252:1134–1141
Mavridis M, Degryse AD, Lategan AJ, Marien MR, Colpaert FC (1991) Effects of locus coeruleus lesions on Parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease. Neuroscience 41:507–523
Mayer A, Limberger N, Starke K (1988) Transmitter release patterns of noradrenergic, dopaminergic and cholinergic axons in rabbit brain slices during short pulse trains, and the operation of presynaptic autoreceptors. Naunyn-Schmiedeberg's Arch Pharmacol 338: 632–643
Medgett IC, McCulloch MW, Rand MJ (1978) Partial agonist action of clonidine on prejunctional and postjunctional α-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 304:215–221
Michel AD, Loury DN, Whiting RL (1989) Differences between the α2-adrenoceptor in rat submaxillary gland and the α2A- and α2B-adrenoceptor subtypes. Br J Pharmacol 98:890–897
Molderings G, Göthert M (1992) Pharmacological characterization of the inhibitory α2-autoreceptors on the sympathetic nerves of the rabbit pulmonary artery. Naunyn-Schmiedeberg' Arch Pharmacol 346 [Suppl]:R64
Muramatsu M, Tamaki-Ohashi J, Usuki C, Araki H, Chaki S, Aihara H (1988) 5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices. Eur J Pharmacol 153:89–95
Nurse B, Russell VA, Taljaard JJF (1984) α2 and β-adrenoceptor agonists modulate [3H]dopamine release from rat nucleus accumbens slices. Neurochem Res 9:1231–1238
Palij P, Bull DR, Sheehan MJ, Millar J, Stamford J, Kruk ZL, Humphrey PPA (1990) Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Res 509:172–174
Racké K, Großhans A, Sirrenberg S, Ziegler K (1988) Presynaptic regulation of the electrically evoked release of endogenous dopamine from the isolated neurointermediate lobe or isolated neural lobe of the rat pituitary gland in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 337:504–511
Reimann W, Steinhauer HB, Hedler L, Starke K, Hertting G (1981) Effect of prostaglandins D2, E2 and F2α on catecholamine release from slices of rat and rabbit brain. Eur J Pharmacol 69:421–427
Russell VA, Nurse B, Lamm MCL, Taljaard JJF (1987) Effect of chronic antidepressant treatment on noradrenergic modulation of [3H]dopamine release form rat nucleus accumbens and striatal slices. Brain Res 410:78–82
Russell VA, Lamm MCL, Taljaard JJF (1993) Lack of interaction between α2-adrenoceptors and dopamine D2-receptors in mediating their inhibitory effects on [3H]dopamine release from rat nucleus accumbens slices. Neurochem Res 18:285–289
Scatton B, Dedek J, Zivkovic B (1983) Lack of involvement of α2-adrenoceptors in the regulation of striatal dopaminergic transmission. Eur J Pharmacol 86:427–433
Schwartz DD, Malik KU (1992) Characterization of prejunctional alpha-2 adrenergic receptors involved in modulation of adrenergic transmitter release in the isolated perfused rat kidney. J Pharmacol Exp Ther 261:1050–1055
Shannak K, Rajput A, Rozdilsky B, Kish S, Gilbert J, Hornykiewicz O (1994) Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects. Brain Res 639:33–41
Simonneaux V, Ebadi M, Bylund DB (1991) Identification and characterization of α2D-adrenergic receptors in bovine pineal gland. Mol Pharmacol 40:235–241
Singer EA (1988) Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms. Trends Pharmacol Sci 9:274–276
Smith K, Docherty JR (1992) Are the prejunctional α2-adrenoceptors of the rat vas deferens and submandibular gland of the α2A- or α2D-subtype? Eur J Pharmacol 219:203–210
Stamford JA (1990) Fast cyclic voltammetry: measuring transmitter release in “real time”. J Neurosci Methods 34:67–72
Starke K (1987) Presynaptic α-autoreceptors. Rev Physiol Biochem Pharmacol 107:73–146
Starke K, Montel H, Gayk W, Merker R (1974) Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 285:133–150
Starke K, Reimann W, Zumstein A, Hertting G (1978) Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 305:27–36
Starke K, Späth L, Lang JD, Adelung C (1983) Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus. Naunyn-Schmiedeberg's Arch Pharmacol 323:298–306
Starke K, Göthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69:864–989
Trendelenburg AU, Limberger N, Starke K (1993) Presynaptic α2-autoreceptors in brain cortex: α2D in the rat and α2A in the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 348:35–45
Trendelenburg AU, Limberger N, Rump LC (1994a) α2-Adrenergic receptors of the α2C subtype mediate inhibition of norepinephrine release in human kidney cortex. Mol Pharmacol 45:1168–1176
Trendelenburg AU, Trendelenburg M, Starke K, Limberger N (1994b) Release-inhibiting α2-adrenoceptors at serotonergic axons in rat and rabbit brain cortex: evidence for pharmacological identity with α2-autoreceptors. Naunyn-Schmiedeberg's Arch Pharmacol 349: 35–43
Ueda H, Goshima Y, Misu Y (1983) Presynaptic mediation by α2-, β1-and β2-adrenoceptors of endogenous noradrenaline and dopamine release from slices of rat hypothalamus. Life Sci 33:371–376
Waldmeier PC, Ortmann R, Bischoff S (1982) Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: evidence for antidopaminergic properties of some alpha antagonists. Experientia 38:1168–1176
Waud DR (1976) Analysis of dose-response relationships. In: Narahashi T, Bianchi CP (eds). Advances in general and cellular pharmacology, vol 1, Plenum, New York, London, pp 145–178
Author information
Authors and Affiliations
Additional information
Correspondence to: N. Limberger at the above address
Rights and permissions
About this article
Cite this article
Trendelenburg, AU., Starke, K. & Limberger, N. Presynaptic α2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices. Naunyn-Schmiedeberg's Arch Pharmacol 350, 473–481 (1994). https://doi.org/10.1007/BF00173016
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173016